Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs 4,713
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Pipeline programs

Page 76 of 99

  1. SC-DARIC33

    Regeneron UK Limited

    Acute Myeloid Leukemia

    phase 1 mab active

    1 trial

  2. SC201 (VICTORIA-01)

    IO Biotech

    advanced/metastatic solid tumors

    phase 1 other active

    1 trial

  3. SC262

    Sana Biotechnology

    Non Hodgkin's Lymphoma

    phase 1 small molecule active

    1 trial

  4. SC291

    Sana Biotechnology

    Lupus Erythematosus

    phase 1 mab active

    1 trial

  5. SC291

    Sana Biotechnology

    Non Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial

  6. SCT-001 CAR-T cells

    Shanghai University of Traditional Chinese Medicine

    Ovarian Cancer

    phase 1 mab active

    1 trial

  7. SCT510

    The First People's Hospital of Lianyungang

    Healthy

    phase 1 small molecule completed

    1 trial

  8. SD-809

    Teva Pharma GmbH

    TOURETTE SYNDROME

    phase 1 small molecule completed

    1 trial

  9. SENTI-202

    Essential Pharma Limited

    AML/MDS

    phase 1 mab active

    1 trial

  10. SER-214

    Serina Therapeutics

    Parkinson's Disease

    phase 1 small molecule active

    1 trial

  11. SER-252 (PEOZ-apomorphine)

    Serina Therapeutics

    PARKINSON DISEASE (Disorder)

    phase 1 small molecule active

    1 trial

  12. SER-262

    Seres Therapeutics

    Clostridium Difficile Infection

    phase 1 small molecule completed

    1 trial

  13. SER-287

    Seres Therapeutics

    Ulcerative Colitis

    phase 1 small molecule completed

    1 trial

  14. SFY17741

    Sanofi-aventis Healthcare Pty Ltd

    Hemophilia A

    phase 1 other active

    1 trial

  15. SGT-212

    Solid Biosciences

    Friedreich's Ataxia (FA)

    phase 1 small molecule active

    1 trial

  16. SGT-501

    Solid Biosciences

    Catecholaminergic Polymorphic Ventricular Tachycardia

    phase 1 small molecule active

    1 trial

  17. SHP465 12.5mg

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    phase 1 small molecule completed

    1 trial

  18. SHP639 (n=60)

    Takeda

    Primary Open-angle Glaucoma (POAG)

    phase 1 small molecule completed

    1 trial

  19. SHP643

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  20. SHP681

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  21. SHR-1501

    Jian Li

    Advanced Malignancies

    phase 1 small molecule completed

    1 trial

  22. SHR1459 tablet

    Jian Li

    B-cell Tumors

    phase 1 small molecule completed

    1 trial

  23. SHR2554 and Itraconazole

    Jian Li

    Healthy Adult Subjects

    phase 1 small molecule completed

    1 trial

  24. SIBP-A13 formulation for injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  25. SIE-1

    Laboratorios Tillomed Spain S.L.U

    Hormone receptor-positive early breast cancer in post-menopausal women

    phase 1 other active

    1 trial

  26. SIG001

    The First People's Hospital of Lianyungang

    Neoplams

    phase 1 mab active

    1 trial

  27. SION-451

    Sionna Therapeutics

    Cystic Fibrosis (CF)

    phase 1 small molecule active

    1 trial

  28. SKSD00702

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  29. SKY0402

    Pacira Ireland Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  30. SKY0402

    Pacira Ireland Limited

    Postoperative Pain Management

    phase 1 small molecule completed

    1 trial

  31. SKY0402 300mg in healthy patients

    Pacira Ireland Limited

    Pain

    phase 1 small molecule completed

    1 trial

  32. SL TNX-102 2.4 mg at pH 3.5

    Tonix Pharmaceuticals Holding

    Healthy Adults

    phase 1 small molecule completed

    1 trial

  33. SL TNX-102 at 2.4 mg

    Tonix Pharmaceuticals Holding

    Healthy Adults

    phase 1 small molecule completed

    1 trial

  34. SLN124

    Silence Therapeutics plc

    Non-transfusion-dependent Thalassemia

    phase 1 small molecule completed

    1 trial

  35. SLN124

    Silence Therapeutics plc

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  36. SLN124-001

    Silence Therapeutics plc

    Non-transfusion-dependent Thalassemia

    phase 1 small molecule terminated

    1 trial

  37. SLN360

    Silence Therapeutics plc

    Hyperlipidemias

    phase 1 small molecule completed

    1 trial

  38. SM25-01

    Swedish Orphan Biovitrum Pty Ltd

    Nicotine use

    phase 1 other active

    1 trial

  39. SMT C1100

    Summit Therapeutics

    Duchenne Muscular Dystrophy

    phase 1 small molecule completed

    1 trial

  40. SMT C1100

    Summit Therapeutics

    Muscular Dystrophy, Duchenne

    phase 1 small molecule completed

    1 trial

  41. SN301A

    Essential Pharma Limited

    Hepatocellular Carcinoma (HCC)

    phase 1 mab active

    1 trial

  42. SNDX-275

    Syndax Pharmaceuticals

    Breast Cancer

    phase 1 small molecule terminated

    1 trial

  43. SNDX-5613

    Syndax Pharmaceuticals

    Acute Myeloid Leukemias

    phase 1 small molecule active

    1 trial

  44. SNDX-5613-0708

    Syndax Pharmaceuticals

    Acute Myeloid Leukemias

    phase 1 other active

    1 trial

  45. SNT-I-VAM-025

    Lacuna Pharma Pty Ltd

    Phase I study in healthy male volunteers. Intended indication: Duchenne muscular dystrophy and Becker muscular dystrophy

    phase 1 other active

    1 trial

  46. SNT-I-VAM-026

    Lacuna Pharma Pty Ltd

    Phase I study in healthy male volunteers. Intended indication: Duchenne muscular dystrophy and Becker muscular dystrophy

    phase 1 other active

    1 trial

  47. SNUCPT08_GCPGC

    Hospital Authority, Hong Kong

    Healthy

    phase 1 small molecule completed

    1 trial

  48. SOC + TSC-100

    TScan Therapeutics

    AML

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.